BBSRC Portfolio Analyser
Award details
Nucleic acid vaccination against respiratory syncytial virus
Reference
BBS/E/I/00000385
Principal Investigator / Supervisor
Dr Geraldine Taylor
Co-Investigators /
Co-Supervisors
Institution
The Pirbright Institute
Department
The Pirbright Institute Department
Funding type
Research
Value (£)
75,788
Status
Completed
Type
Institute Project
Start date
01/04/1997
End date
31/08/1997
Duration
5 months
Abstract
Vaccination against RSV has proved difficult, particularly in humans, with many candidate vaccine causing more adverse reactions that the natural infection. Given the potential of DNA vaccination, with its inherent lack of unwanted immunogenic material, this project will look in model systems developed by the IAH at the efficacy of various constructs given by various routes on their ability to stimulate protective immunity without unwanted side-effects.
Summary
unavailable
Committee
Closed Committee - Animal Sciences (AS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search